Analyst Ratings for Jasper Therapeutics (JSPR)
JSPR Rating Summary
JSPR Price Target Summary
- Highest: $70.00 (RBC Capital)
- Lowest: $7.00 (CapitalOne)
- Average: $47.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$47.33 (+123.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$47.33 (+123.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/3/2024 | Evercore ISI | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
65.00 (N/A) |
26.20 (21.18) |
-19.16% | Details |
| 3/27/2024 | RBC Capital | Gregory Renza | New Coverage | Outperform (N/A) |
70.00 (N/A) |
27.89 (21.18) |
-24.06% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
